Autor: "Werthenbach JP" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
Autorzy:: Schiffmann LM; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC) and Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, CECAD Research Center, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. .; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. .; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany. .
Göbel H; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.; Institute of Pathology, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Löser H; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.; Institute of Pathology, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Schorn F; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC) and Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, CECAD Research Center, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
Werthenbach JP; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC) and Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, CECAD Research Center, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
Fuchs HF; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Plum PS; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Bludau M; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Zander T; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.; Department I of Internal Medicine, University of Cologne, Kerpener Str. 62, 50924, Cologne, Germany.
Schröder W; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Bruns CJ; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Kashkar H; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC) and Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, CECAD Research Center, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.
Quaas A; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.; Institute of Pathology, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Gebauer F; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO) Cologne Bonn, Kerpener Str. 62, 50924, Cologne, Germany.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2019 May 31; Vol. 19 (1), pp. 531. Date of Electronic Publication: 2019 May 31.
Typ publikacji:: Journal Article
MeSH Terms:: Neoadjuvant Therapy*/methods
Adenocarcinoma/*metabolism
Adenocarcinoma/*mortality
Esophageal Neoplasms/*metabolism
Esophageal Neoplasms/*mortality
Lymphocytes, Tumor-Infiltrating/*metabolism
T-Lymphocyte Subsets/*metabolism
X-Linked Inhibitor of Apoptosis Protein/*metabolism
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Biomarkers, Tumor/metabolism ; Esophageal Neoplasms/pathology ; Esophageal Neoplasms/therapy ; Esophagectomy ; Female ; Humans ; Immunohistochemistry ; Lymph Nodes/pathology ; Male ; Prognosis ; Retrospective Studies ; Survival Rate
SCR Disease Name:: Adenocarcinoma Of Esophagus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Werthenbach JP"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język